MICHAEL HARRISON: Open Payments
NPI 1215786439 · SANFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $130 |
| Novo Nordisk Inc | 4 | $94 |
| Grifols USA, LLC | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| ABBVIE INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Circassia Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: Korlym, Prolastin-C Liquid, Wegovy, DUPIXENT, CAPLYTA, Ozempic, VRAYLAR, Kerendia.
Industry payments across NC — which companies pay providers there.
